Clinical Trial Update: SWAN: Study on the Tolerance and Efficacy of a New Anti-regurgitation Formula (PC-2016-01) [NA]

View source ↗

Summary

A completed clinical trial evaluating the tolerance and efficacy of PC-2016-01, an anti-regurgitation formula, for gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• PC-2016-01

Snippet

Sponsor: United Pharmaceuticals | Conditions: Gastroesophageal Reflux | NA | Status: COMPLETED